LegalNewsLine Logo  
Friday, February 10 2012 Twitter  feedburner  yahoo  Subscribe in NewsGator Online
News | Contact LegalNewsline | About Us | Advertise | RSS
Enter search keyword
 
clear
clear
NEWSLETTER
Receive our FREE weekly newsletter
click here
Today's Offers:

LNL MOST POPULAR ARTICLES
+ Vermont GOP wants Sorrell to look into possible union bullying
+ Hood critical of bill that would allow officials to hire outside attorneys
+ More than 40 states have signed on to proposed mortgage deal
+ Study shows plaintiff bias in Philly courts
+ Man, startled by bottle rocket shot out of anus, sues frat
LNL HOT TOPICS
+ Asbestos
+ Big Pharma
+ BP Oil Spill
+ Class Action
+ Dickie Scruggs
+ Federal Government
+ Financial Crisis
+ Global Warming
+ Hurricane Katrina
+ Lead Paint
+ Sub-Prime Mortgages
+ Tobacco
Big Pharma 
story date  
Conn. announces settlement in Zyprexa case
blumenthal.jpg
Blumenthal
HARTFORD, Conn. (Legal Newsline) - Another settlement has been announced in the final round of Zyprexa lawsuits brought by state attorneys general.

Eli Lilly & Co. is paying the State of Connecticut $25.1 million to settle allegations that the company marketed Zyprexa for off-label uses, and that the drug caused weight gain-related side effects like diabetes and hypertension.

After a $62 million settlement with state attorneys general, 12 states with claims remained. Most have settled, though the terms have not been announced yet. West Virginia settled its claim in August for more than $22 million, with $6.75 million going to private lawyers hired by state Attorney General Darrell McGraw.

"This illicit multi-billion dollar drug marketing scheme corrupted health care at the expense of taxpayers, senior citizens, children and others who suffered serious side effects from Zyprexa," Blumenthal said.

"Eli Lilly was aided and abetted by so-called independent physicians paid handsomely to promote Zyprexa for unapproved off-label uses -- ghost writing articles, downplaying dangers, and pitching the product.

Eli Lilly also agreed to pay $1.4 billion to settle federal civil and criminal claims stemming from the alleged off-label marketing.

The payment also benefited the Medicaid programs of more than 30 states that collectively received approximately $362 million.

In a 10-Q filing with the Securities and Exchange Commission, Lilly revealed in July that it incurred special charges of $105 million in the second quarter.

"We are in advanced discussions with the attorneys general for several states that were not part of the Eastern District of Pennsylvania settlement, seeking to resolve their Zyprexa-related claims, and we have reached settlement with the State of West Virginia," the filing says.

"The charge represents the currently probable and estimable exposures in connection with the states' claims."

Only Mississippi now has an unsettled case before U.S. District Judge Jack Weinstein. The other three, brought by South Carolina, Arkansas and Pennsylvania, are located in state courts.

The trial in South Carolina's case begins Monday. It can be viewed on Courtroom View Network.

Other settlements will be announced in the cases brought by the attorneys general of Utah, Montana, Idaho, Louisiana, Minnesota and New Mexico.

From Legal Newsline: Reach John O'Brien by e-mail at jobrienwv@gmail.com.

Filed Under: Hot Topics

E-mail this article to a friend | Printer friendly format

MORE NEWS HEADLINES:
+ Thirty-three states settle antitrust claims - 1/31   read more
+ UPDATE: Texas AG's Risperdal settlement worth $158M - 1/19   read more
+ Texas AG's Risperdal suit goes to trial - 1/10   read more
+ Texas, Actavis reach $84M settlement - 12/28   read more
+ Judge rules against GSK in Paxil mass tort - 12/19   read more
+ Miss. AWP settlements worth more than $6M - 10/24   read more
+ Pfizer settles over false Detrol claims - 10/21   read more
+ Digitek lawyers broke rules, attorney claims - 10/10   read more
+ Merck paying $1.6M in Idaho settlement - 9/29   read more
+ Three AGs reach $70M settlement with Watson - 9/16   read more


IN THE SPOTLIGHT:
garrett.jpg
Wednesday, February 08, 2012
PHILADELPHIA (Legal Newsline) - A roundtable of federal and state judges from across the country will convene at the posh Ritz Carlton on Feb. 9 to address topics such as "Can MDL's keep up with state court trial settings;" "Priority of deposition examination;" "State and federal cooperation;" and "Forum non conveniens."
Read more...


+ Study shows plaintiff bias in Philly courts - 2/6
+ Fannie Mae offers examples of routine dishonesty in its fight against lenders - 2/3
+ Quaker City courts have troubled history; some reject 'plaintiff-friendly' criticism - 1/31
+ Madison County asbestos docket feeds off intake firm referrals - 1/19
+ Torts conference set for Feb. 8 in Philly - 1/18
BROWSE BY STATE:
 
BROWSE BY AG:
 
BROWSE BY DATE:
 
NEWS WIDGET:
Attention bloggers:
Add Record Headlines to your site!


fast + free- click here
NEWS | CONTACT LEGALNEWSLINE | ABOUT US | ADVERTISE | RSS © 2008 LegalNewsLine.com. All Rights Reserved.